Video: Video Gallery
GSK aims to market first malaria vaccine (2:05)
Oct 8 - British drug maker GlaxoSmithKline will seek marketing approval for the world's first malaria vaccine next year after trial data showed it significantly cut cases of the disease in African children. As Joanna Partridge reports it will be welcome news for a UK company recently battered by a corruption scandal in China. ( Transcript )
Hard-edged reporting, insight and analysis, Reuters TV breaks ground creating informative news and financial videos. Showcasing Reuters’ 3000 award-winning journalists, Reuters TV delivers high-energy investigative journalism with concise explanations. Check it out and let us know what you think.